Evidence map›Paper›PMID 26446116›Full record

ArticleSleep2016

Deletion of the Snord116/SNORD116 Alters Sleep in Mice and Patients with Prader-Willi Syndrome.

Glenda Lassi, Lorenzo Priano, Silvia Maggi, Celina Garcia-Garcia, Edoardo Balzani, Nadia El-Assawy, Marco Pagani, Federico Tinarelli, Daniela Giardino, Alessandro Mauro and 4 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Sleep, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05939453 (A Randomized, Double-Blind, Controlled Trial of Bright Light Therapy on All-Cause Excessive Daytime Sleepiness in Prader-Willi Syndrome), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05939453 narecruitingnot on this mapstarted 2023, after this paper: background citation

A Randomized, Double-Blind, Controlled Trial of Bright Light Therapy on All-Cause Excessive Daytime Sleepiness in Prader-Willi Syndrome

TypeinterventionalSponsorMaimonides Medical CenterRan2023 to 2026Enrolled50ConditionsPrader-Willi Syndrome, Excessive Daytime Sleepiness, Hyperphagia, Body WeightArmsSham Light, Bright Light Therapy
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Light and sex modifybioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Sleep Consequences of Prader-Willi Syndrome.Current neurology and neuroscience reports · 2023
    Review
  9. Prader-Willi and Angelman Syndromes: Mechanisms and Management.The application of clinical genetics · 2023
    Review
  10. Article
  11. Review
  12. Diagnosis and management of sleep disorders in Prader-Willi syndrome.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Glenda LassiNeuroscience and Brain Technologies (NBT) Department, Istituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova (Italy).
Lorenzo PrianoDepartment of Neurology and Neurorehabilitation, S. Giuseppe Hospital, IRCCS Istituto Auxologico Italiano, Piancavallo (VB), Italy. Department of Neurosciences, University of Turin, Italy.
Silvia MaggiNeuroscience and Brain Technologies (NBT) Department, Istituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova (Italy).
Celina Garcia-GarciaNeuroscience and Brain Technologies (NBT) Department, Istituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova (Italy).
Edoardo BalzaniNeuroscience and Brain Technologies (NBT) Department, Istituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova (Italy).
Nadia El-AssawyDepartment of Neurology and Neurorehabilitation, S. Giuseppe Hospital, IRCCS Istituto Auxologico Italiano, Piancavallo (VB), Italy. Department of Neurosciences, University of Turin, Italy.
Marco PaganiIstituto Italiano di Tecnologia. Center for Neuroscience and Cognitive Systems, Rovereto, Italy.
Federico TinarelliNeuroscience and Brain Technologies (NBT) Department, Istituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova (Italy).
Daniela GiardinoLaboratory of Medical Cytogenetics, Istituto Auxologico Italiano, Cusano Milanino (MI), Italy.
Alessandro MauroDepartment of Neurology and Neurorehabilitation, S. Giuseppe Hospital, IRCCS Istituto Auxologico Italiano, Piancavallo (VB), Italy. Department of Neurosciences, University of Turin, Italy.
Jo PetersMRC Harwell, Harwell Science and Innovation Campus, Oxfordshire, OX11 0RD, UK.
Alessandro GozziIstituto Italiano di Tecnologia. Center for Neuroscience and Cognitive Systems, Rovereto, Italy.
Graziano GrugniDivision of Auxology, S. Giuseppe Hospital, Research Institute, Istituto Auxologico Italiano, Piancavallo di Oggebbio (VB), Verbania, Italy.
Valter TucciNeuroscience and Brain Technologies (NBT) Department, Istituto Italiano di Tecnologia (IIT), via Morego 30, 16163 Genova (Italy).
Italian Institute of Technology · ITIRCCS Istituto Auxologico Italiano · ITCenter for Neuroscience and Cognitive Systems · ITMary Lyon Centre at MRC Harwell · GBUniversity of Trento · IT

Funding

Medical Research Council MC_U142636336
6 · The paper itself

Abstract

STUDY

objectivesSleep-wake disturbances are often reported in Prader-Willi syndrome (PWS), a rare neurodevelopmental syndrome that is associated with paternally-expressed genomic imprinting defects within the human chromosome region 15q11-13. One of the candidate genes, prevalently expressed in the brain, is the small nucleolar ribonucleic acid-116 (SNORD116). Here we conducted a translational study into the sleep abnormalities of PWS, testing the hypothesis that SNORD116 is responsible for sleep defects that characterize the syndrome.

methodsWe studied sleep in mutant mice that carry a deletion of Snord116 at the orthologous locus (mouse chromosome 7) of the human PWS critical region (PWScr). In particular, we assessed EEG and temperature profiles, across 24-h, in PWScr (m+/p-) heterozygous mutants compared to wild-type littermates. High-resolution magnetic resonance imaging (MRI) was performed to explore morphoanatomical differences according to the genotype. Moreover, we complemented the mouse work by presenting two patients with a diagnosis of PWS and characterized by atypical small deletions of SNORD116. We compared the individual EEG parameters of patients with healthy subjects and with a cohort of obese subjects.

resultsBy studying the mouse mutant line PWScr(m+/p-), we observed specific rapid eye movement (REM) sleep alterations including abnormal electroencephalograph (EEG) theta waves. Remarkably, we observed identical sleep/EEG defects in the two PWS cases. We report brain morphological abnormalities that are associated with the EEG alterations. In particular, mouse mutants have a bilateral reduction of the gray matter volume in the ventral hippocampus and in the septum areas, which are pivotal structures for maintaining theta rhythms throughout the brain. In PWScr(m+/p-) mice we also observed increased body temperature that is coherent with REM sleep alterations in mice and human patients.

conclusionsOur study indicates that paternally expressed Snord116 is involved in the 24-h regulation of sleep physiological measures, suggesting that it is a candidate gene for the sleep disturbances that most individuals with PWS experience.

Indexed as

AdultAnimalsBrainCase-Control StudiesCircadian RhythmCohort StudiesElectroencephalographyFemaleGenotypeGray MatterHippocampusHumansMaleMiceObesityPaternal InheritanceRNA, Small NucleolarSNORD116 RNA, humanSNORD116 RNA, mousePrader-WillisleepSnord116temperaturetheta rhythms

Identifiers

PMID26446116
PMCPMC4763347
OpenAlexW2312758384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.